Skip to main content

Rocket Pharmaceuticals, Inc.

RCKT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001281895

In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.

Q2 2023 vs. Q1 2023

How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of RCKT: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders163164+1
Shares78.3M76.4M−1.91M (−2.4%)
Value$1.34B$1.52B+$176.7M (+13.2%)

New holders (18)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to RCKT in Q2 2023
InstitutionSharesValue% of portfolio
PFM Health Sciences, LP238,762$4.74M0.19%
Millennium Management LLC179,216$3.56M0.00%
Ghost Tree Capital, LLC75,000$1.49M0.54%
Healthcare of Ontario Pension Plan Trust Fund41,000$814.7K0.00%
Jennison Associates LLC33,679$669.2K0.00%
HRT Financial LP33,014$655.0K0.01%
Schonfeld Strategic Advisors LLC30,124$598.6K0.01%
Sanders Morris Harris LLC27,709$553.1K0.12%
Tudor Investment Corp Et Al22,873$454.5K0.01%
Squarepoint Ops LLC16,561$329.1K0.00%
Virtu Financial LLC14,435$287.0K0.02%
Y-Intercept (Hong Kong) Ltd14,089$279.9K0.03%
Handelsbanken Fonder AB12,300$244.0K0.00%
Efg Capital International Corp.11,711$232.7K0.05%
Prudential Financial Inc15,575$225.1K0.00%
Aquatic Capital Management LLC2,000$40.0K0.00%
Huntington National Bank480$9.54K0.00%
Gradient Investments LLC34$6760.00%

Sold out (17)

Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.